The Hindu : Andhra Pradesh News : Drug trial successful at NIMS

Online edition of India's National Newspaper
Wednesday, Nov 17, 2004

Andhra Pradesh

Andhra Pradesh

Drug trial successful at NIMS

By Our Staff Reporter

HYDERABAD, NOV. 16. The Nizam Institute of Medical Sciences (NIMS) has become one of the few recognised centres for conducting human clinical drug trials in India with the successful completion of the Phase I trial of a new antiseptic drug.

Announcing this to the press here on Tuesday, M.U.R. Naidu, Head, Department of Clinical Pharmacology and Therapeutics, said that the drug they had tested, was an anti-bacterial agent from the Qunolenes group of drugs and was developed by an Indian pharma company. The Drugs Controller General of India had recognised NIMS as a competent centre for Phase I trials.

Phase I clinical trials are the first trials on human beings and test the safety and side-effects of the drug on human beings. Dr. Naidu said that a total of 30 human subjects were involved in Phase I which was completed in a record time of seven months only. With the successful completion of this phase, the drug will now be administered to actual patients to test its efficacy to fight bacterial infections.

Cure for deadly infection

Speaking about the possible use of this new drug, Y.S. Raju, Department of General Medicine, said that it was the first drug, which claimed to treat the serious "life-threatening" MRSA infection. It can attack any organ of the body and lead to septisemia and death, if untreated.

Printer friendly page
Send this article to Friends by E-Mail

Andhra Pradesh